Global Compounding Pharmacy Market 2024

SKU ID :GC-26903779 | Published Date: 25-Feb-2024 | No. of pages: 87
TABLE OF CONTENTS FIGURES AND TABLES PART 1. INTRODUCTION 1.1 Description 1.2 Objectives of The Study 1.3 Market Segment 1.4 Years Considered for The Report 1.5 Currency 1.6 Key Target Audience PART 2. RESEARCH METHODOLOGY 2.1 Primary Research 2.2 Secondary Research PART 3. EXECUTIVE SUMMARY PART 4. MARKET OVERVIEW 4.1 Introduction 4.2 Drivers 4.3 Restraints PART 5. GLOBAL COMPOUNDING PHARMACY MARKET BY THERAPEUTIC AREA 5.1 Pain management 5.2 Hormone replacement 5.3 Dermal disorders 5.4 Nutritional supplements 5.5 Others PART 6. GLOBAL COMPOUNDING PHARMACY MARKET BY ROUTE OF ADMINISTRATION 6.1 Oral 6.2 Topical 6.3 Parenteral 6.4 Others PART 7. GLOBAL COMPOUNDING PHARMACY MARKET BY END USER 7.1 Humans 7.2 Veterinary PART 8. GLOBAL COMPOUNDING PHARMACY MARKET BY REGION 8.1 North America 8.2 Europe 8.3 Asia-Pacific 8.4 MEA (Middle East and Africa) 8.5 Latin America PART 9. COMPANY PROFILES 9.1 B. Braun Melsungen AG 9.2 Dougherty's Pharmacy Inc. 9.3 Fagron NV 9.4 Fresenius SE & Co. KGaA 9.5 Institutional Pharmacy Solutions LLC 9.6 Nephron Pharmaceuticals Corporation 9.7 Pharmasave Drugs (National) Ltd. 9.8 Valor Compounding Pharmacy Inc. 9.9 Wedgewood Village Pharmacy LLC DISCLAIMER
  • PRICE
  • $1590
    $3180
    $2390

Our Clients